Tag Archive

The following is a list of all entries tagged with markets:

Drug Patent Settlements Cost Consumers US$3.5bn annualy in the USA

a ban on patent settlements between brand and generic drugmakers would reduce spending on prescription drugs by $3.5 billion each year


The pharmaceutical industry faces unprecedented barriers to evolution

The article argues that the pharmaceutical industry’s evolving business model in response to growing regualtory contraints has so far helped it maintain profits and growth will face some serious challenges in the near future